Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient.
Acanthamoeba is 1 of 3 genera of free-living amebae that commonly cause disease in humans (1). These protozoa have been implicated in local infections, such as amebic keratitis, mainly in immunocompetent contact lens wearers, and in the mostly fatal, granulomatous amebic encephalitis in immunocompromised patients with HIV/ AIDS and immunosuppressant-treated patients, including organ transplant recipients (2-4). Disseminated acanthamebiasis (DA), which is defined as widespread extracerebral disease, is extremely rare, but its incidence has increased in recent years (5). Among DA reported, only 5 occurred in solid organ (3 lung and 2 kidney) transplant recipients (4). We report a fatal case of DA in a heart transplant recipient and identify Acanthamoeba lenticulata (genotype T5) as the cause of life-threatening disease.
A 39-year-old man from Martinique had received a second heart transplant in March 2004 because of chronic rejection. He had received his first transplant 14 years earlier because of alcohol-related dilated cardiomyopathy. Skin complications included epidermoid carcinoma on the fight leg in 1995 and diffuse viral warts on the trunk in 2003. Maintenance immunosuppression after the second heart transplant in 2004 included cyclosporine (220 mg/ day), prednisone (20 mg/day), and mycophenolate mofetil (500 mg/day). The latter drug was withdrawn because of pancytopenia. Postsurgery complications included acute refractory bleeding (aortic anastomosis), cytomegalovirus infection of the gut, bacterial pulmonary infection, and postoperative renal failure that required chronic hemodialysis that prolonged his stay in the intensive care unit (ICU) to 5 months.
In January 2006, after a short visit to Martinique, the patient was transferred to our institution because of fever, dyspnea, and acute costal and back pain, with suspected osteitis underlying cutaneous lesions. Two months earlier, 4 trunk and leg abscesses or carbunclelike skin lesions had developed. Despite oral antistaphylococcal therapy, these lesions spread and became ulcerated and painful. Three ulcerated, violaceous plaques with undermined deep-infiltrated margins were present: 1 on the trunk (largest diameter 5 cm) (Figure, panel A) and 1 on each thigh. Three subcutaneous abscesses were present on the trunk and their puncture yielded a brown liquid. The differential diagnosis included pyoderma gangrenosum, neutrophilic dermatoses, mycobacteriosis, cutaneous bacterial infection, and calciphylaxis (chronic hemodialysis).
The first histologic examination of a periulcerated skin lesion (punch biopsy specimen) showed diffuse dermal and hypodermal neutrophil infiltration and sparse histiocytelike cells (Figure, panel B). No infectious elements were identified. Biologic data indicated an inflammatory syndrome (Creactive protein 250 mg/L [normal <5 mg/L], procalcitonin 25 ng/mL [normal <1 ng/mL]), with increased elevated circulating neutrophil counts (10.9 x [10.sup.9] cells/L) and anemia (hemoglobin 7 g/dL). Cultures of blood, abscess fluid, and involved skin were repeatedly negative for bacterial, mycotic, or parasitic agents. A computed tomographic body scan showed a massive abscess under the left kidney associated with pulmonary nodules without cutaneous calciphylaxis. Positron emission tomography scan confirmed those abnormalities and showed extensive and severe bone osteomyelitis.
Atypical pyoderma gangrenosum with visceral involvement was considered and treated with 3 intravenous prednisolone pulses. After minor initial improvement, the patient's condition deteriorated, and 10 days later septic shock associated with multiorgan failure developed. Surgical periulcer skin biopsy specimens were obtained in the ICU and specific parasite investigations were conducted. DA was then diagnosed. Hematoxylin and eosin staining of histologic sections showed cysts and trophozoites (30 lam diameter) in the dermal-hypodermal junction within polymorphous inflammatory granulomas associated with ischemic necrosis (Figure, panels C and D). The presence of Acanthamoeba sp. was confirmed by culturing amebae from involved skin on agar plates coated with Escherichia coli. In an indirect assay, the patient's serum showed weak immunofluorescence labeling against his own cultured cysts or vegetative amebae.
Molecular identification of DNA extracted from the isolated amebae was made by using the UNSET method (6). A diagnostic small subunit rDNA fragment (ASA.S1) was amplified by using JDP1 and JDP2 primers, and its differentiating fragment (DF3) was sequenced by using an internal 892c primer (7). The sequence of the DF3 subset that contains the highly variable and informative section in the ASA.S 1 region of the Acanthamoeba isolate was visually compared with those of different published genotypes (T1-T15) (Table). Genotype T5 was identified (European Molecular Biology Laboratory accession no. AM411530). No drug-of-choice exists for treating DA. Despite treatment with pentamidine, 5-fluorocytosine, and itraconazole, the infection was rapidly fatal. Although analysis of cerebrospinal fluid obtained on days 5 and 18 after admission to the ICU showed no biochemical or parasite data suggestive of granulomatous amebic encephalitis, callus corpus necrosis was observed on a computed tomographic brain scan on day 18. The patient died of multiorgan failure on day 23. Family members refused to allow an autopsy.
Protozoan infections are rare in heart transplant recipients, unlike in lung transplant recipients (8,9). To our knowledge, our patient, whose DA involved skin, bones, lungs, intraabdominal organs, and perhaps the brain, represents the first case to be reported in a heart transplant recipient. In a recent review of the literature, Duarte et al. (4) reported 5 cases of DA in lung (60%) or kidney (40%) transplant recipients. DA was difficult to diagnose in the patient, with 60% of the diagnoses made postmortem, which is similar to 74% of the diagnoses in 23 HIV/AIDS patients (2). The patient's clinical picture was atypical because his lesions were pyodermalike ulcers with subcutaneous abscesses, whereas the most frequently reported clinical skin manifestations were painful nodules, purpura, and pustules (10). Furthermore, the first histologic examination did not identify cysts. Acanthamoeba trophozoites with characteristic acanthopodia, cytoplasmic vacuoles, and a prominent nucleolus, especially in dermal vessels, were observed only after staining of the second biopsy specimen with hematoxylin and eosin in a context of strong clinical suspicion of DA. When reexamined retrospectively, the first skin biopsy specimen contained some pathogens, but trophozoites had been misidentified as histiocytelike cells.
Another important finding was the identification of the DA-causative agent as genotype T5, which is commonly found in the environment (11) and corresponds to A. lenticulata. This species has been isolated from nasal mucosa of persons without documented amebic infection (12). Although A. lenticulata has been shown to be pathogenic (12), genotype T5 was only recently isolated from a patient with keratitis (13). To our knowledge, our patient has the first case in which genotype T5 is the etiologic agent of a nonkeratitis, life-threatening DA infection.
Acanthamoeba spp. are free-living amebae found in soil, water, air, humans, and various animals (14). Depending on the molecular methods used (i.e., nuclear 18S rRNA or 16S rRNA mitochondrial gene amplification), 15 genotype sequences have been identified in environmental and human strains (T1-T15, Table). While genotype T4 is the most prevalent (79% of isolates) (15), only 1 A. lenticulata strain isolated from a patient with ocular keratitis had genotype T5 (13).
This case should alert physicians to a rare but life-threatening infection with A. lenticulata (genotype T5) in a heart transplant recipient. In organ transplant patients, when sterile cutaneous ulcers or subcutaneous abscesses develop that fail to respond to antibacterial treatments and pulse corticosteroids, histologic analysis should emphasize identifying Acanthamoeba spp.
We thank Janet Jacobson for editorial assistance.
(1.) Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev. 2003; 16:273-307.
(2.) Murakawa GJ, McCalmont T, Altman J, Telang GH, Hoffman MD, Kantor GR, et al. Disseminated acanthamebiasis in patients with AIDS. A report of five cases and a review of the literature. Arch Dermatol. 1995;131:1291-6.
(3.) Shirwadkar CG, Samant R, Sankhe M, Deshpande R, Yagi S, Schuster FL, et al. Acanthamoeba encephalitis in patient with systemic lupus, India. Emerg Infect Dis. 2006;12:984-6.
(4.) Duarte AG, Sattar F, Granwehr B, Aronson JF, Wang Z, Lick S. Disseminated acanthamoebiasis after lung transplantation. J Heart Lung Transplant. 2006;25:237-40.
(5.) Steinberg JP, Galindo RL, Kraus ES, Ghanem KG. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clin Infect Dis. 2002;35:e43-9.
(6.) Hugo ER, Stewart VJ, Gast R J, Byers TJ. Purification of amoeba mtDNA using the UNSET procedure. In: Soldo AT, Lee JJ, editors. Protocols in protozoology. Lawrence (KS): Allen Press; 1992. p. D-7.1-2.
(7.) Booton GC, Kelly DJ, Chu YW, Seal DV, Houang E, Lam DS, et al. 18S ribosomal DNA typing and tracking of Acanthamoeba species isolates from corneal scrape specimens, contact lenses, lens cases, and home water supplies of Acanthamoeba keratitis patients in Hong Kong. J Clin Microbiol. 2002;40:1621-5.
(8.) Smart FW, Naftel DC, Costanzo MR, Levine TB, Pelletier GB, Yancy CW Jr, et al. Risk factors for early, cumulative, and fatal infections alter heart transplantation: a multiinstitutional study. J Heart Lung Transplant. 1996;15:329-41.
(9.) Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2004;170:22-48.
(10.) van Hamme C, Dumont M, Delos M, Lachapelle JM. Cutaneous acanthamoebiasis in a lung transplant patient. Ann Dermatol Venereol. 2001;128:1237-40.
(11). Schroeder JM, Booton GC, Hay J, Niszl IA, Seal DV, Markus MB, et al. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol. 2001;39:1903-11.
(12.) de Jonckheere JF, Michel R. Species identification and virulence of Acanthamoeba strains from human nasal mucosa. Parasitol Res. 1988;74:314-6.
(13.) Spanakos G, Tzanetou K, Miltsakakis D, Patsoula E, Malamou-Lada E, Vakalis NC. Genotyping of pathogenic acanthamoebae isolated from clinical samples in Greece: report of a clinical isolate presenting T5 genotype. Parasitol Int. 2006;55:147-9.
(14.) de Jonckheere JF. Ecology of Acanthamoeba. Rev Infect Dis. 1991;13(Suppl 5):S385-7.
(15.) Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol. 2005;43: 1689-93.
Dr Barete is a dermatologist at the Hopital Tenon of the Universite Pierre-et-Marie-Curie in Paris. His research interests include infectious complications, mycotic skin infections, Kaposi sarcoma, and Epstein-Barr virus lymphoproliferation in organ transplant recipients.
Address for correspondence: Stephane Barete, Department of Dermatology and Allergy, Hopital Tenon, Assistance Publique Hopitaux de Paris, 4 rue de la Chine, 75970 Paris CEDEX 20, France; email: stephane.barete@ psl.aphp.fr
Stephane Barete, * Alain Combes, ([dagger]) Johan F. de Jonckheere, ([double dagger]) Annick Datry, ([dagger]) Shaida Varnous, ([dagger]) Valdrie Martinez, ([dagger]) Sara Garcia Ptacek, * Eric Caumes, ([dagger]) Frederique Capron, ([dagger]) Camille Frances, * Claude Gibert, ([dagger]) and Olivier Chosidow *
* Hopital Tenon, Paris, France; ([dagger]) Hopital Pitie-Salpetriere, Paris, France; and ([double dagger]) Scientific Institute of Public Health, Brussels, Belgium
Table. rDNA sequences of Acanthamoeba isolate (2/533) from the patient, a keratitis isolate (GAK1), 3 environmental T5 subtypes, and 4 other genotypes from persons with nonkeratitis infections Genotype (strain) DF3 sequence (5' [right arrow] 3') * T5(2/533) CAAAACACCGCCGTTAATCCTTTTT-- CGGGGGTTAACGGTTGGTGAAT T5(GAK1) CAAAACACCGCCGTTAATCCTTT-- CGGGGGTTAATGGTTGGTGAAT T5(72/2) ([dagger]) CAAAACACCGCCGTTAATCCTTT-- CGGGGGTTAATGGTTGGTGAAT T5(PD2S) ([double dagger]) CAAAACACCGCTGTTAATCCTTT-- CGGGGGTTAATAGTTGGTGAAT T5(FLAIV) ([section]) CAAAACACCGCCGTTAATCCTTTT- CAACGGGGGTTAACGGTTGGTGAAT T4 CAAAACACCAATCGGCGCGGTCGTCCTTGGCGTCGGT CCTTCACGGGGCCGGCGCGAGGGCGGCTTAGCCCGGT GGCACC T1 CAAAACACCACCATCAGGCAGTGGGGTCGTGCTTCGC TTTTCCGGCAACGGGGAAGTGGAGGCGGTCTCATTCC CCTGATGG T10 CAAAACACCATCCATTTAGCAYGGTCGTTTTCAAATA TTCCTTTTTGCGAAGGTTGTTTGGGAACGATTCGTCC TGATGGATC T12 CAAAACACCACCATTAACACGATCGTTTTTTGCAAAT ATGCCACATGCGCAAGTGTGTGGTTGTGTTTGAAGGA ACGATTTG * Sequence differences are shown in boldface. ([dagger]) Five isolates at European Molecular Biology Laboratory (EMBL). ([double dagger]) Eight isolates at EMBL. ([section]) One isolate at EMBL.